PRME Q3'26 Earnings Preview: EPS Estimated at $(0.24)
Prime Medicine is scheduled to report Q3'26 results on October 30; EPS is estimated at $(0.24). The report time is not specified.
PRME (Prime Medicine, Inc.) is set to announce its Q3'26 results on October 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 1.33 million USD with EPS (earnings per share) anticipated at (0.24) USD. Learn more details at P…